Last reviewed · How we verify
Ibuprofen continuous infusion
Ibuprofen continuous infusion is a Small molecule drug developed by Federal Research and Clinical Centre of Intensive Care Medicine and Rehabilitology. It is currently FDA-approved.
At a glance
| Generic name | Ibuprofen continuous infusion |
|---|---|
| Sponsor | Federal Research and Clinical Centre of Intensive Care Medicine and Rehabilitology |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies (PHASE1)
- Psychosocial Factors and Postoperative Pain in Aesthetic Breast Surgery
- Modified Thoracoabdominal Nerve Plane Block In Laparoscopic Sleeve Gastrectomy (NA)
- Continuous vs. Bolus Administration of NSAIDs After Laparoscopic Surgery for Multimodal Analgesia (PHASE4)
- PVB vs Ketamine/Lidocaine in Rib Fracture Patients (EARLY_PHASE1)
- Efficacy of Ketamine for Improvement in Postoperative Pain Control After Spinal Fusion for Idiopathic Scoliosis (PHASE4)
- Ibuprofen Use on Post-operative Pain Following Cholecystectomy (PHASE4)
- The Application of Thoracic Epidural Analgesia in Patients With Acute Pancreatitis (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Ibuprofen continuous infusion CI brief — competitive landscape report
- Ibuprofen continuous infusion updates RSS · CI watch RSS
- Federal Research and Clinical Centre of Intensive Care Medicine and Rehabilitology portfolio CI
Frequently asked questions about Ibuprofen continuous infusion
What is Ibuprofen continuous infusion?
Ibuprofen continuous infusion is a Small molecule drug developed by Federal Research and Clinical Centre of Intensive Care Medicine and Rehabilitology.
Who makes Ibuprofen continuous infusion?
Ibuprofen continuous infusion is developed and marketed by Federal Research and Clinical Centre of Intensive Care Medicine and Rehabilitology (see full Federal Research and Clinical Centre of Intensive Care Medicine and Rehabilitology pipeline at /company/federal-research-and-clinical-centre-of-intensive-care-medicine-and-rehabilitolo).
What development phase is Ibuprofen continuous infusion in?
Ibuprofen continuous infusion is FDA-approved (marketed).
Related
- Manufacturer: Federal Research and Clinical Centre of Intensive Care Medicine and Rehabilitology — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing